Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

195 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Erratum: Favorable efficacy and reduced acute neurotoxicity by antisense oligonucleotides with 2',4' -BNA/LNA with 9-(aminoethoxy)phenoxazine.
Matsubayashi T, Yoshioka K, Lei Mon SS, Katsuyama M, Jia C, Yamaguchi T, Hara RI, Nagata T, Nakagawa O, Obika S, Yokota T. Matsubayashi T, et al. Among authors: nakagawa o. Mol Ther Nucleic Acids. 2024 Apr 2;35(2):102182. doi: 10.1016/j.omtn.2024.102182. eCollection 2024 Jun 11. Mol Ther Nucleic Acids. 2024. PMID: 38590918 Free PMC article.
Digenic inheritance involving a muscle-specific protein kinase and the giant titin protein causes a skeletal muscle myopathy.
Töpf A, Cox D, Zaharieva IT, Di Leo V, Sarparanta J, Jonson PH, Sealy IM, Smolnikov A, White RJ, Vihola A, Savarese M, Merteroglu M, Wali N, Laricchia KM, Venturini C, Vroling B, Stenton SL, Cummings BB, Harris E, Marini-Bettolo C, Diaz-Manera J, Henderson M, Barresi R, Duff J, England EM, Patrick J, Al-Husayni S, Biancalana V, Beggs AH, Bodi I, Bommireddipalli S, Bönnemann CG, Cairns A, Chiew MT, Claeys KG, Cooper ST, Davis MR, Donkervoort S, Erasmus CE, Fassad MR, Genetti CA, Grosmann C, Jungbluth H, Kamsteeg EJ, Lornage X, Löscher WN, Malfatti E, Manzur A, Martí P, Mongini TE, Muelas N, Nishikawa A, O'Donnell-Luria A, Ogonuki N, O'Grady GL, O'Heir E, Paquay S, Phadke R, Pletcher BA, Romero NB, Schouten M, Shah S, Smuts I, Sznajer Y, Tasca G, Taylor RW, Tuite A, Van den Bergh P, VanNoy G, Voermans NC, Wanschitz JV, Wraige E, Yoshimura K, Oates EC, Nakagawa O, Nishino I, Laporte J, Vilchez JJ, MacArthur DG, Sarkozy A, Cordell HJ, Udd B, Busch-Nentwich EM, Muntoni F, Straub V. Töpf A, et al. Among authors: nakagawa o. Nat Genet. 2024 Mar;56(3):395-407. doi: 10.1038/s41588-023-01651-0. Epub 2024 Mar 1. Nat Genet. 2024. PMID: 38429495 Free PMC article.
The WATCH-DM risk score estimates clinical outcomes in type 2 diabetic patients with heart failure with preserved ejection fraction.
Iwakura K, Onishi T, Okamura A, Koyama Y, Tanaka N, Okada M, Fujii K, Seo M, Yamada T, Yano M, Hayashi T, Yasumura Y, Nakagawa Y, Tamaki S, Nakagawa A, Sotomi Y, Hikoso S, Nakatani D, Sakata Y; PURSUIT-HFpEF Investigators. Iwakura K, et al. Sci Rep. 2024 Jan 19;14(1):1746. doi: 10.1038/s41598-024-52101-8. Sci Rep. 2024. PMID: 38243047 Free PMC article.
β-blockers may be detrimental in frail patients with heart failure with preserved ejection fraction.
Hikoso S, Kida H, Sunaga A, Nakatani D, Okada K, Dohi T, Sotomi Y, Oeun B, Sato T, Matsuoka Y, Kitamura T, Yamada T, Kurakami H, Tamaki S, Seo M, Yano M, Hayashi T, Nakagawa A, Nakagawa Y, Yamada T, Yasumura Y, Sakata Y; OCVC-Heart Failure investigators. Hikoso S, et al. Clin Res Cardiol. 2024 Jun;113(6):842-855. doi: 10.1007/s00392-023-02301-5. Epub 2023 Nov 29. Clin Res Cardiol. 2024. PMID: 38019285
Pathophysiological insights into machine learning-based subphenotypes of acute heart failure with preserved ejection fraction.
Sotomi Y, Tamaki S, Hikoso S, Nakatani D, Okada K, Dohi T, Sunaga A, Kida H, Sato T, Matsuoka Y, Sakamoto D, Kitamura T, Komukai S, Seo M, Yano M, Hayashi T, Nakagawa A, Nakagawa Y, Ohtani T, Yasumura Y, Yamada T, Sakata Y; OCVC-Heart Failure Investigators. Sotomi Y, et al. Heart. 2024 Feb 23;110(6):441-447. doi: 10.1136/heartjnl-2023-323059. Heart. 2024. PMID: 37827559
A genetic and developmental biological approach for a family with complex congenital heart diseases-evidence of digenic inheritance.
Yoshida Y, Uchida K, Kodo K, Ishizaki-Asami R, Maeda J, Katsumata Y, Yuasa S, Fukuda K, Kosaki K, Watanabe Y, Nakagawa O, Yamagishi H. Yoshida Y, et al. Among authors: nakagawa o. Front Cardiovasc Med. 2023 Apr 25;10:1135141. doi: 10.3389/fcvm.2023.1135141. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37180804 Free PMC article.
Medications for specific phenotypes of heart failure with preserved ejection fraction classified by a machine learning-based clustering model.
Sotomi Y, Hikoso S, Nakatani D, Okada K, Dohi T, Sunaga A, Kida H, Sato T, Matsuoka Y, Kitamura T, Komukai S, Seo M, Yano M, Hayashi T, Nakagawa A, Nakagawa Y, Tamaki S, Ohtani T, Yasumura Y, Yamada T, Sakata Y; OCVC-Heart Failure Investigator. Sotomi Y, et al. Heart. 2023 Jul 27;109(16):1231-1240. doi: 10.1136/heartjnl-2022-322181. Heart. 2023. PMID: 36822821 Free PMC article.
Canonical Wnt signaling activation by chimeric antigen receptors for efficient cardiac differentiation from mouse embryonic stem cells.
Sogo T, Nakao S, Tsukamoto T, Ueyama T, Harada Y, Ihara D, Ishida T, Nakahara M, Hasegawa K, Akagi Y, Kida YS, Nakagawa O, Nagamune T, Kawahara M, Kawamura T. Sogo T, et al. Among authors: nakagawa o. Inflamm Regen. 2023 Feb 10;43(1):11. doi: 10.1186/s41232-023-00258-6. Inflamm Regen. 2023. PMID: 36765434 Free PMC article.
195 results